Gilead Sciences, Inc. (GILD)
USD 90.69
(-2.27%)
USD 90.69
(-2.27%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 3.36 Billion USD | 19.36% |
| 2022 | 2.82 Billion USD | 3.15% |
| 2021 | 2.73 Billion USD | -9.29% |
| 2020 | 3.01 Billion USD | 45.82% |
| 2019 | 2.06 Billion USD | 153.93% |
| 2018 | 814 Million USD | 1.62% |
| 2017 | 801 Million USD | -49.53% |
| 2016 | 1.58 Billion USD | -18.82% |
| 2015 | 1.95 Billion USD | 41.05% |
| 2014 | 1.38 Billion USD | -32.58% |
| 2013 | 2.05 Billion USD | 17.81% |
| 2012 | 1.74 Billion USD | 25.54% |
| 2011 | 1.38 Billion USD | 15.47% |
| 2010 | 1.2 Billion USD | 14.46% |
| 2009 | 1.05 Billion USD | 13.35% |
| 2008 | 927.86 Million USD | 54.65% |
| 2007 | 599.96 Million USD | 6.35% |
| 2006 | 564.14 Million USD | 160.09% |
| 2005 | 216.9 Million USD | 59.5% |
| 2004 | 135.99 Million USD | 38.62% |
| 2003 | 98.1 Million USD | 90.02% |
| 2002 | 51.62 Million USD | 31.44% |
| 2001 | 39.28 Million USD | 91.03% |
| 2000 | 20.56 Million USD | -2.09% |
| 1999 | 21 Million USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| 1994 | - USD | 0.0% |
| 1992 | - USD | 0.0% |
| 1991 | - USD | 0.0% |
| 1990 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 1.85 Billion USD | -44.95% |
| 2024 Q2 | 2.02 Billion USD | 9.34% |
| 2023 FY | 3.36 Billion USD | 19.36% |
| 2023 Q1 | 3.01 Billion USD | 6.74% |
| 2023 Q3 | 3.2 Billion USD | 0.66% |
| 2023 Q2 | 3.18 Billion USD | 5.68% |
| 2023 Q4 | 3.36 Billion USD | 5.12% |
| 2022 Q1 | 2.67 Billion USD | -2.16% |
| 2022 Q3 | 2.6 Billion USD | 74.16% |
| 2022 FY | 2.82 Billion USD | 3.15% |
| 2022 Q2 | 1.49 Billion USD | -44.15% |
| 2022 Q4 | 2.82 Billion USD | 8.38% |
| 2021 Q1 | 2.99 Billion USD | -0.6% |
| 2021 Q2 | 2.98 Billion USD | -0.27% |
| 2021 Q3 | 2.79 Billion USD | -6.39% |
| 2021 Q4 | 2.73 Billion USD | -2.25% |
| 2021 FY | 2.73 Billion USD | -9.29% |
| 2020 Q3 | 1.95 Billion USD | -0.71% |
| 2020 Q2 | 1.96 Billion USD | -2.67% |
| 2020 FY | 3.01 Billion USD | 45.82% |
| 2020 Q1 | 2.02 Billion USD | -2.23% |
| 2020 Q4 | 3.01 Billion USD | 54.33% |
| 2019 Q1 | 898 Million USD | 10.32% |
| 2019 Q3 | 882 Million USD | -0.23% |
| 2019 Q2 | 884 Million USD | -1.56% |
| 2019 FY | 2.06 Billion USD | 153.93% |
| 2019 Q4 | 2.06 Billion USD | 134.35% |
| 2018 Q3 | 816 Million USD | -5.01% |
| 2018 Q2 | 859 Million USD | -2.94% |
| 2018 Q4 | 814 Million USD | -0.25% |
| 2018 Q1 | 885 Million USD | 10.49% |
| 2018 FY | 814 Million USD | 1.62% |
| 2017 FY | 801 Million USD | -49.53% |
| 2017 Q4 | 801 Million USD | -29.98% |
| 2017 Q3 | 1.14 Billion USD | -18.75% |
| 2017 Q2 | 1.4 Billion USD | -4.48% |
| 2017 Q1 | 1.47 Billion USD | -7.12% |
| 2016 Q3 | 1.9 Billion USD | 2.04% |
| 2016 Q1 | 1.88 Billion USD | -3.84% |
| 2016 Q2 | 1.86 Billion USD | -0.96% |
| 2016 Q4 | 1.58 Billion USD | -16.47% |
| 2016 FY | 1.58 Billion USD | -18.82% |
| 2015 Q2 | 2.03 Billion USD | 6.87% |
| 2015 Q4 | 1.95 Billion USD | -1.66% |
| 2015 FY | 1.95 Billion USD | 41.05% |
| 2015 Q3 | 1.98 Billion USD | -2.5% |
| 2015 Q1 | 1.9 Billion USD | 37.66% |
| 2014 Q4 | 1.38 Billion USD | -27.42% |
| 2014 Q3 | 1.9 Billion USD | -7.69% |
| 2014 Q2 | 2.06 Billion USD | -3.34% |
| 2014 FY | 1.38 Billion USD | -32.58% |
| 2014 Q1 | 2.14 Billion USD | 4.11% |
| 2013 Q4 | 2.05 Billion USD | 5.64% |
| 2013 Q3 | 1.94 Billion USD | 0.56% |
| 2013 FY | 2.05 Billion USD | 17.81% |
| 2013 Q1 | 1.79 Billion USD | 3.13% |
| 2013 Q2 | 1.93 Billion USD | 7.53% |
| 2012 Q2 | 1.6 Billion USD | 13.07% |
| 2012 FY | 1.74 Billion USD | 25.54% |
| 2012 Q4 | 1.74 Billion USD | 7.89% |
| 2012 Q3 | 1.61 Billion USD | 0.87% |
| 2012 Q1 | 1.41 Billion USD | 2.02% |
| 2011 FY | 1.38 Billion USD | 15.47% |
| 2011 Q4 | 1.38 Billion USD | 3.9% |
| 2011 Q3 | 1.33 Billion USD | 1.22% |
| 2011 Q2 | 1.32 Billion USD | 1.32% |
| 2011 Q1 | 1.3 Billion USD | 8.36% |
| 2010 Q4 | 1.2 Billion USD | -5.46% |
| 2010 Q1 | 1.22 Billion USD | 16.37% |
| 2010 FY | 1.2 Billion USD | 14.46% |
| 2010 Q2 | 1.35 Billion USD | 10.84% |
| 2010 Q3 | 1.27 Billion USD | -6.13% |
| 2009 Q3 | 1.01 Billion USD | 4.93% |
| 2009 Q1 | 936.72 Million USD | 0.95% |
| 2009 Q4 | 1.05 Billion USD | 3.33% |
| 2009 FY | 1.05 Billion USD | 13.35% |
| 2009 Q2 | 969.97 Million USD | 3.55% |
| 2008 Q2 | 856.28 Million USD | 29.53% |
| 2008 Q1 | 661.09 Million USD | 10.19% |
| 2008 Q4 | 927.86 Million USD | 3.37% |
| 2008 Q3 | 897.62 Million USD | 4.83% |
| 2008 FY | 927.86 Million USD | 54.65% |
| 2007 FY | 599.96 Million USD | 6.35% |
| 2007 Q3 | 565.69 Million USD | -1.33% |
| 2007 Q1 | 522.41 Million USD | -7.4% |
| 2007 Q2 | 573.34 Million USD | 9.75% |
| 2007 Q4 | 599.96 Million USD | 6.06% |
| 2006 Q3 | 373.26 Million USD | 17.12% |
| 2006 Q2 | 318.71 Million USD | 42.05% |
| 2006 Q4 | 564.14 Million USD | 51.14% |
| 2006 Q1 | 224.37 Million USD | 3.44% |
| 2006 FY | 564.14 Million USD | 160.09% |
| 2005 FY | 216.9 Million USD | 59.5% |
| 2005 Q4 | 216.9 Million USD | 24.63% |
| 2005 Q3 | 174.04 Million USD | 4.81% |
| 2005 Q2 | 166.06 Million USD | 22.55% |
| 2005 Q1 | 135.5 Million USD | -0.36% |
| 2004 Q3 | 116.23 Million USD | 9.69% |
| 2004 Q2 | 105.96 Million USD | 4.65% |
| 2004 Q1 | 101.25 Million USD | 3.21% |
| 2004 FY | 135.99 Million USD | 38.62% |
| 2004 Q4 | 135.99 Million USD | 17.0% |
| 2003 FY | 98.1 Million USD | 90.02% |
| 2003 Q4 | 98.1 Million USD | 20.59% |
| 2003 Q3 | 81.35 Million USD | 28.05% |
| 2003 Q2 | 63.53 Million USD | 12.41% |
| 2003 Q1 | 56.52 Million USD | 9.48% |
| 2002 Q1 | 46.19 Million USD | 17.61% |
| 2002 Q4 | 51.62 Million USD | 35.26% |
| 2002 Q3 | 38.16 Million USD | -10.56% |
| 2002 Q2 | 42.67 Million USD | -7.62% |
| 2002 FY | 51.62 Million USD | 31.44% |
| 2001 Q3 | 31.2 Million USD | 31.56% |
| 2001 Q1 | 20.53 Million USD | -0.12% |
| 2001 FY | 39.28 Million USD | 91.03% |
| 2001 Q4 | 39.28 Million USD | 25.87% |
| 2001 Q2 | 23.72 Million USD | 15.5% |
| 2000 Q4 | 20.56 Million USD | 6.94% |
| 2000 Q2 | 20.29 Million USD | -3.31% |
| 2000 Q1 | 20.98 Million USD | -0.07% |
| 2000 FY | 20.56 Million USD | -2.09% |
| 2000 Q3 | 19.22 Million USD | -5.25% |
| 1999 Q3 | 20.1 Million USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q4 | 21 Million USD | 4.48% |
| 1999 Q1 | - USD | -100.0% |
| 1999 FY | 21 Million USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q4 | 16.6 Million USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1993 Q1 | - USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1993 Q4 | - USD | 0.0% |
| 1992 Q1 | - USD | 0.0% |
| 1992 Q3 | - USD | 0.0% |
| 1992 FY | - USD | 0.0% |
| 1992 Q4 | - USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| 1990 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Amgen Inc. | 9.51 Billion USD | 64.635% |
| AstraZeneca PLC | 5.42 Billion USD | 37.942% |
| Biogen Inc. | 2.52 Billion USD | -33.18% |
| MIRA Pharmaceuticals, Inc. | -11.86 Thousand USD | 28376427.769% |
| Scilex Holding Company | 4.21 Million USD | -79776.602% |
| Scilex Holding Company | 4.21 Million USD | -79776.602% |